Skip to main content

. 1981 Feb 7;282(6262):438–439. doi: 10.1136/bmj.282.6262.438

Androgens, oestrogens, and coronary heart disease.

R F Heller, H S Jacobs, A Vermeulen, J P Deslypere

PMCID: PMC1504277 PMID: 6780063

438

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Entrican J. H., Beach C., Carroll D., Klopper A., Mackie M., Douglas A. S. Raised plasma oestradiol and oestrone levels in young survivors of myocardial infarction. Lancet. 1978 Sep 2;2(8088):487–490. doi: 10.1016/s0140-6736(78)92215-8. [DOI] [PubMed] [Google Scholar]
Heller R. F., Jacobs H. S. Coronary heart disease in relation to age, sex, and the menopause. Br Med J. 1978 Feb 25;1(6111):472–474. doi: 10.1136/bmj.1.6111.472. [DOI] [PMC free article] [PubMed] [Google Scholar]
Heller R. F. Type A behaviour and coronary heart disease. Br Med J. 1979 Aug 11;2(6186):368–368. doi: 10.1136/bmj.2.6186.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
McKerron C. G., Scott R. L., Asper S. P., Levy R. I. Effects of clofibrate (Atromid S) on the thyroxine-binding capacity of thyroxine-binding globulin and free thyroxine. J Clin Endocrinol Metab. 1969 Jul;29(7):957–961. doi: 10.1210/jcem-29-7-957. [DOI] [PubMed] [Google Scholar]
Phillips G. B. Evidence for hyperoestrogenaemia as a risk factor for myocardial infarction in men. Lancet. 1976 Jul 3;2(7975):14–18. doi: 10.1016/s0140-6736(76)92968-8. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES